HCA

HCA Healthcare
D

HCA

Arincen59/100B

HCA Healthcare stock buybacks 1990–2026

HCA Healthcare spent 2.97B USD buying back its shares in Q3 FY2026, the three months to 30 September 2026, up 18.9% on the same quarter a year before. HCA Healthcare spent 9.16B USD buying back its shares over the last twelve months, down 0.5% on the twelve months before. In fiscal year 2025 it spent 10.07B USD, up 66.6% on the year before.

Last updated 7 Nov 2026 · Next report 26 Jan 2027

Stock buybacks

Growth

Fiscal yearPeriod endingStock buybacksGrowthDividends paidFree cash flow
TTM30 Sept 20269.16B-0.50%681.00M5.97B
FY202531 Dec 202510.07B+66.62%679.00M7.69B
FY202431 Dec 20246.04B+58.54%690.00M5.64B
FY202331 Dec 20233.81B-45.56%661.00M4.69B
FY202231 Dec 20227.00B-14.79%653.00M4.13B
FY202131 Dec 20218.22B+1,762.81%624.00M5.38B
FY202031 Dec 2020441.00M-57.23%153.00M6.40B
FY201931 Dec 20191.03B-32.61%550.00M3.44B
FY201831 Dec 20181.53B-25.40%487.00M3.19B
FY201731 Dec 20172.05B-25.45%0.002.41B
FY201631 Dec 20162.75B+14.77%0.002.89B
FY201531 Dec 20152.40B+36.97%0.002.36B
FY201431 Dec 20141.75B+250.00%7.00M2.27B
FY201331 Dec 2013500.00M—16.00M1.74B
FY201231 Dec 20120.00-100.00%3.15B2.31B
FY201131 Dec 20111.50B—31.00M2.25B
FY201031 Dec 20100.00—4.26B1.76B
FY200931 Dec 20090.00—0.001.43B
FY200831 Dec 20080.00—0.00197.00M
FY200731 Dec 20070.00-100.00%0.00-48.00M
FY200631 Dec 200621.02B+1,032.38%201.00M-20.00M
FY200531 Dec 20051.86B-40.30%258.00M1.57B
FY200431 Dec 20043.11B+179.08%199.00M1.54B
FY200331 Dec 20031.11B+295.04%39.00M328.00M
FY200231 Dec 2002282.00M-81.27%40.00M1.03B
FY200131 Dec 20011.51B—42.00M43.00M
FY200031 Dec 20000.00—44.00M392.00M
FY199931 Dec 19990.00—0.00-64.00M
FY199831 Dec 19980.00-100.00%0.00661.00M
FY199731 Dec 19971.08B—0.0061.00M
FY199631 Dec 19960.00—54.00M1.22B
FY199531 Dec 19950.00—50.00M727.00M
FY199431 Dec 19940.00—36.00M326.00M
FY199331 Dec 19930.00—40.00M462.00M
FY199231 Dec 19920.00—4.00M-36.60M
FY199131 Dec 19910.00—3.50M-20.00M
FY199031 Dec 19900.00—3.90M-4.10M

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

The money spent buying back the company's own shares in each period, from the cash flow statement.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Cash flow

Common questions about HCA Healthcare's buybacks

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.